| Bioactivity | RIBI-529 (RC-529), a lipid A mimetic (aminoalkyl glucosaminide 4-phosphate), is a adjuvant with a similar efficacy to MPL (Corixa). RIBI-529 signals through Toll-like receptor 4 to stimulate the innate immune system[1]. |
| Name | RIBI-529 |
| CAS | 216014-46-9 |
| Formula | C98H190N3O17P |
| Molar Mass | 1713.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jay T Evans, et al. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev Vaccines. 2003 Apr;2(2):219-29. |
RIBI-529
CAS: 216014-46-9 F: C98H190N3O17P W: 1713.54
RIBI-529 (RC-529), a lipid A mimetic (aminoalkyl glucosaminide 4-phosphate), is a adjuvant with a similar efficacy to MP
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.